Aldagen is a biotechnology company advancing a pipeline of
clinical-stage regenerative therapies. The company has three
product candidates in clinical development for chronic heart
failure, critical limb ischemia and pediatric metabolic
and malignancies. ALDAGEN's therapeutics are produced by a
proprietary technology platform that selects potent, adult
and progenitor cells for therapeutic use. The platform yields
broad range of therapeutic cells that can be used rapidly,
culture or expansion.
Argos develops immunotherapy treatments for cancer. The
centers on the use of dendritic cells and tumor RNA which
constitute a vaccine. The research team is based at Duke
University Medical Center and has been working on the
for several years.
The CardioFocus Catheter promises rapid, effective and
isolation of the pulmonary veins while overcoming the
inherent in the current RF ablation procedures. Guided via
integrated endoscopic visualization, the catheter helps
to accomplish ablation by projecting a series of overlapping
of both visible and infrared laser light upon the atrial wall
surrounding each vein. Complete isolation is generally
with several 60-second energy deliveries - promising a great
advantage in speed and precision in comparison to the large
of ablations required in current RF ablation procedures.
Cardioxyl Pharmaceuticals' mission is the discovery and
of new classes of safe and effective therapeutic agents for
treatment of cardiovascular disease. Cardioxyl's initial
a novel medication for the treatment of acute decompensated
failure. Cardioxyl is located in Towson, Maryland.
Cropsolution is focused on chemical crop protection. The
company will use its proprietary Evolutionary Chemistry
to discover and develop novel agrochemicals for protecting
from diseases,weeds, and insect pests, addressing current
opportunities totaling $30B.
Hyperbranch is a biosurgical device company that is founded on
patent-pending, broad-platform polymer technology. By
polymer chemistry and biomedical engineering, HyperBranch
scientists have developed unique dendritic polymers that
highly tunable properties for medical and surgical
Since inception, HyperBranch researchers have been developing
solid knowledge base for surgical applications and use on a
variety of wound types. The company has identified specific
products for the surgical sealant market and for other
including organ and tissue restoration and drug delivery.
Metabolon is a leader in the application of metabolomics, a
and powerful scientific approach, for the discovery and
development of drugs.
Natus is a medical device company that develops,
and markets proprietary, non-invasive medical instruments and
related disposables for use in diagnosing diseases in newborn
infants and children. Natus had its IPO in July 2001 (NASDAQ:
Neotropix 1 is a leading-edge virotherapy company,
dedicated to the development and commercialization of
therapies for the treatment of cancer and other diseases.
Virotherapy holds great promise for cancer patients because it
be more efficacious and less toxic than conventional radiation
ParinGenix is developing a proprietary, modified form of
heparin to treat a range of inflammatory diseases. The
lead drug, called PGX-100 is targeting acute exacerbations of
chronic obstructive pulmonary disease, COPD, for which there
currently only marginally effective treatments. The company
completed Phase I testing and is in the planning stages for
II COPD trials. Additional disease targets for the company's
technology include following reperfusion damage in
myocardial infarctions and stroke.
Regado is a biotechnology company whose vision is to
be the world leader in the discovery, development, and
commercialization of regulatable therapeutics.
therapeutics are designed to enhance physician control and
TriVirix is a full service contract manufacturing company
on the manufacture and design support of complex
electro-mechanical medical, diagnostic, analytical and
life-science devices. TriVirix can support companies' life
needs, from design completion through production or at any
United Emergency Services (UES) is a physician contract
company that focuses on providing experienced emergency
physicians and other health care providers to single hospital
communities in the Southeastern United States.
Virologic is a biotechnology company that performs,
and markets drug susceptibility and resistance tests to be
optimizing the treatment of patients with serious viral
infections. Virologic had its IPO in May 2000 (NASDAQ: